Excess body weight and specific types of depressive symptoms: Is there a mediating role of systemic low-grade inflammation?

Body mass index C-reactive protein Cognitive-affective depressive symptoms Excess body weight Inflammation Mediation Obesity Overweight Somatic depressive symptoms

Journal

Brain, behavior, and immunity
ISSN: 1090-2139
Titre abrégé: Brain Behav Immun
Pays: Netherlands
ID NLM: 8800478

Informations de publication

Date de publication:
Feb 2023
Historique:
received: 19 05 2022
revised: 25 11 2022
accepted: 26 11 2022
pubmed: 4 12 2022
medline: 25 1 2023
entrez: 3 12 2022
Statut: ppublish

Résumé

Obesity is associated with an increased risk of depression. Systemic low-grade inflammation, a plausible consequence of obesity, has also been linked to depression. However, the potential mediating effects of systemic low-grade inflammation on the association between excess body weight and specific symptom domains of depression remain uncertain. This study examined whether systemic low-grade inflammation mediated the associations of excess body weight (overweight and obesity) with subsequent overall, cognitive-affective, and somatic depressive symptoms. This study used a prospective cohort design. The final analytical sample included 4,942 adults aged ≥50 years drawn from the English Longitudinal Study of Ageing (ELSA). Body mass index (BMI) and covariates were ascertained at baseline (wave 4, 2008/09). Continuous BMI scores were divided into four categories: 'normal weight' (18.5 ≤ BMI <25 kg/m In multivariable-adjusted analyses, excess body weight was associated with elevated somatic (OR = 1.231, 95% CI: 1.029, 1.473), but not cognitive-affective or overall depressive symptoms at follow-up. Higher CRP was associated with elevated somatic (OR = 1.156, 95% CI: 1.061, 1.259), but not cognitive-affective or overall depressive symptoms. CRP acted as a partial mediator (14.92%) of the association between excess body weight and elevated somatic, but not cognitive-affective, or overall depressive symptoms. Systemic low-grade inflammation may partially explain the association of excess body weight with somatic depressive symptoms, but not the associations with cognitive-affective or overall depressive symptoms.

Identifiants

pubmed: 36462595
pii: S0889-1591(22)00454-8
doi: 10.1016/j.bbi.2022.11.016
pmc: PMC10567582
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

233-244

Informations de copyright

Copyright © 2022 The Author(s). Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Références

Front Psychiatry. 2019 Nov 21;10:858
pubmed: 31824355
Int J Epidemiol. 2013 Dec;42(6):1640-8
pubmed: 23143611
Int J Geriatr Psychiatry. 2015 Sep;30(9):976-84
pubmed: 25537199
Hepatology. 1999 Dec;30(6):1356-62
pubmed: 10573511
Lancet. 2017 Sep 16;390(10100):1211-1259
pubmed: 28919117
J Am Geriatr Soc. 2011 Jan;59(1):67-72
pubmed: 21226677
Nat Immunol. 2012 Jul 19;13(8):707-12
pubmed: 22814340
Arterioscler Thromb Vasc Biol. 1999 Apr;19(4):972-8
pubmed: 10195925
Climacteric. 2012 Oct;15(5):419-29
pubmed: 22978257
Am J Public Health. 1999 Sep;89(9):1346-52
pubmed: 10474551
Front Endocrinol (Lausanne). 2014 May 15;5:74
pubmed: 24860551
Behav Res Methods. 2009 Nov;41(4):1149-60
pubmed: 19897823
Brain Behav Immun. 2009 Oct;23(7):936-44
pubmed: 19416750
Int J Epidemiol. 2012 Dec;41(6):1585-93
pubmed: 22253315
Obesity (Silver Spring). 2013 Feb;21(2):248-50
pubmed: 23404927
BMC Med. 2013 May 15;11:129
pubmed: 23672628
Psychol Methods. 2001 Dec;6(4):330-51
pubmed: 11778676
J Clin Psychiatry. 2010 Apr;71(4):391-9
pubmed: 20021992
Neuropsychopharmacology. 2017 Jan;42(1):115-128
pubmed: 27402495
J Clin Invest. 2003 Dec;112(12):1821-30
pubmed: 14679177
Aliment Pharmacol Ther. 2006 Jun 1;23(11):1629-35
pubmed: 16696813
Int J Obes (Lond). 2009 Dec;33(12):1410-8
pubmed: 19786964
Mol Psychiatry. 2020 May;25(5):1130-1140
pubmed: 31435001
Biol Psychiatry. 2007 Aug 15;62(4):321-6
pubmed: 17241618
BMC Med. 2017 Nov 30;15(1):210
pubmed: 29187192
Brain Behav Immun. 2012 Jul;26(5):717-20
pubmed: 22056839
Public Health. 2007 Jul;121(7):497-509
pubmed: 17544467
Mol Psychiatry. 2021 Jul;26(7):3302-3314
pubmed: 32807846
Mol Psychiatry. 2019 Jan;24(1):18-33
pubmed: 29453413
Nat Rev Immunol. 2016 Jan;16(1):22-34
pubmed: 26711676
Ann Intern Med. 2006 Jul 18;145(2):91-7
pubmed: 16847291
Obes Surg. 2007 Jun;17(6):759-63
pubmed: 17879575
J Gastroenterol. 2007 Jul;42(7):573-82
pubmed: 17653654
Am J Psychiatry. 2021 Dec;178(12):1107-1118
pubmed: 34645276
Psychol Med. 2018 May;48(7):1102-1110
pubmed: 28889804
Psychoneuroendocrinology. 2018 Sep;95:149-157
pubmed: 29864671
Exp Gerontol. 2018 Feb;102:109-132
pubmed: 29237576
J Clin Endocrinol Metab. 2014 Jan;99(1):E53-61
pubmed: 24243638
Alcohol Clin Exp Res. 1993 Oct;17(5):1112-7
pubmed: 8279675
Int J Geriatr Psychiatry. 2011 Nov;26(11):1109-18
pubmed: 21370276
Nat Rev Neurosci. 2008 Jan;9(1):46-56
pubmed: 18073775
Psychopharmacology (Berl). 2016 May;233(9):1669-78
pubmed: 25877654
Lancet Diabetes Endocrinol. 2022 Apr;10(4):253-263
pubmed: 35248171
Exp Gerontol. 2007 Jul;42(7):693-701
pubmed: 17350781
Metab Syndr Relat Disord. 2011 Feb;9(1):1-12
pubmed: 20973675
Mol Psychiatry. 2019 Jul;24(7):965-986
pubmed: 30254236
Pharmacol Ther. 2011 May;130(2):226-38
pubmed: 21334376
BMC Psychiatry. 2013 Sep 12;13:223
pubmed: 24028572
Front Neuroendocrinol. 2020 Jan;56:100800
pubmed: 31654681
Arch Gen Psychiatry. 2010 Jun;67(6):598-607
pubmed: 20530009
Biomark Med. 2015;9(3):277-97
pubmed: 25731213
JAMA Psychiatry. 2017 Dec 1;74(12):1214-1225
pubmed: 29049554
Transl Psychiatry. 2020 May 12;10(1):140
pubmed: 32398645
Biodemography Soc Biol. 2017;63(2):131-147
pubmed: 28521620
Gastroenterology. 2007 May;132(6):2169-80
pubmed: 17498510
Am J Geriatr Psychiatry. 2010 Nov;18(11):1036-44
pubmed: 20808088
Circulation. 2004 Dec 21;110(25):e545-9
pubmed: 15611379
Int Psychogeriatr. 1999 Jun;11(2):139-48
pubmed: 11475428
Int J Obes Relat Metab Disord. 2003 Apr;27(4):514-21
pubmed: 12664085
J Neurosci. 2009 Feb 18;29(7):2089-102
pubmed: 19228962
Brain Behav Immun. 2017 Mar;61:27-30
pubmed: 27562420

Auteurs

Keqin Chu (K)

Department of Behavioural Science and Health, University College London, London, UK. Electronic address: keqin.chu.17@ucl.ac.uk.

Dorina Cadar (D)

Department of Behavioural Science and Health, University College London, London, UK; Brighton and Sussex Medical School, Brighton, East Sussex, UK. Electronic address: d.cadar@bsms.ac.uk.

Eleonora Iob (E)

Social, Genetic & Developmental Psychiatry (SGDP) Centre, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK. Electronic address: eleonora.iob.17@ucl.ac.uk.

Philipp Frank (P)

Department of Behavioural Science and Health, University College London, London, UK. Electronic address: philipp.frank.16@ucl.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH